
News
Here you will find financial news from APONTIS PHARMA as well as other publications relevant to the capital market.
Latest News
Corporate News
31.01.2023 | EQS-News
APONTIS PHARMA extends portfolio for the treatment of hypertension and hyperlipidemia by...
EQS-News: APONTIS PHARMA AG/ Key word(s): Product Launch APONTIS PHARMA extends portfolio for the treatment of...
Corporate News
29.11.2022 | EQS-News
APONTIS PHARMA: Number of announced market launches increases to ten Single Pills – Portfolio grows...
EQS-News: APONTIS PHARMA AG/ Key word(s): Product Launch APONTIS PHARMA: Number of announced market launches...
Corporate News
10.11.2022 | EQS-News
APONTIS PHARMA confirms 2022 forecast after successful nine-month period – Strong Single Pill...
EQS-News: APONTIS PHARMA AG/ Key word(s): 9 Month figures/Quarterly/ Interim Statement APONTIS PHARMA confirms 2022...
Corporate News
20.09.2022 | EQS-News
APONTIS PHARMA announces cooperation to launch new Single Pill in Germany
EQS-News: APONTIS PHARMA AG/ Key word(s): Alliance/Product Launch APONTIS PHARMA announces cooperation to launch new...
Corporate News
01.09.2022 | DGAP-News
APONTIS PHARMA: SECURE study and START study add-on analysis confirm superior efficacy of Single Pill
DGAP-News: APONTIS PHARMA AG/ Key word(s): Scientific publication APONTIS PHARMA: SECURE study and START study...
Corporate News
11.08.2022 | DGAP-News
APONTIS PHARMA expands profitable positioning in first half of 2022 – full-year forecast confirmed
DGAP-News: APONTIS PHARMA AG/ Key word(s): Half Year Report/Half Year Results APONTIS PHARMA expands profitable...
Corporate News
19.07.2022 | DGAP-News
APONTIS PHARMA and Midas Pharma agree on further development partnership for the market launch of a...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Alliance/Market launch APONTIS PHARMA and Midas Pharma agree on further...
Corporate News
06.07.2022 | DGAP-News
APONTIS PHARMA rolls out new Single Pill for secondary prophylaxis
DGAP-News: APONTIS PHARMA AG/ Key word(s): Market launch APONTIS PHARMA rolls out new Single Pill for secondary...
Corporate News
23.06.2022 | DGAP-News
APONTIS PHARMA AG: Notice according to Article 2 paragraph 1 of Delegated Regulation (EU) 2016/1052
DGAP-News: APONTIS PHARMA AG/ Key word(s): Share Buyback APONTIS PHARMA AG: Notice according to Article 2 paragraph...
Corporate News
25.05.2022 | DGAP-News
APONTIS PHARMA launches two new single pills - medium-term revenue potential of EUR 8.2 million
DGAP-News: APONTIS PHARMA AG/ Key word(s): Product Launch APONTIS PHARMA launches two new single pills- medium-term...
Corporate News
12.05.2022 | DGAP-News
APONTIS PHARMA holds Annual General Meeting 2022 - shareholders approve all agenda items with large...
DGAP-News: APONTIS PHARMA AG/ Key word(s): AGM/EGM APONTIS PHARMA holds Annual General Meeting 2022- shareholders...
Corporate News
10.05.2022 | DGAP-News
APONTIS PHARMA continues strong profitable growth in Q1 2022
DGAP-News: APONTIS PHARMA AG/ Key word(s): Quarterly/ Interim Statement APONTIS PHARMA continues strong profitable...
Corporate News
05.05.2022 | DGAP-News
APONTIS PHARMA and Develco Pharma enter development partnership for launch of two Single Pills with...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Product Launch APONTIS PHARMA and Develco Pharma enter development...
Corporate News
20.04.2022 | DGAP-News
APONTIS PHARMA: START study published in scientific journal - Cost reduction in the treatment of...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Scientific publication APONTIS PHARMA: START study published in...
Corporate News
16.03.2022 | DGAP-News
APONTIS PHARMA: START study published in scientific journal - Lower incidence of cardiovascular...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Scientific publication 16.03.2022/ 07:30 The issuer is solely responsible...
Corporate News
15.03.2022 | DGAP-News
APONTIS PHARMA AG: Notice according to Article 2 paragraph 1 of Delegated Regulation (EU) 2016/1052
DGAP-News: APONTIS PHARMA AG/ Key word(s): Share Buyback 15.03.2022/ 07:30 The issuer is solely responsible for the...
Corporate News
08.03.2022 | DGAP-News
APONTIS PHARMA and AstraZeneca extend strategic sales cooperation
DGAP-News: APONTIS PHARMA AG/ Key word(s): Alliance 08.03.2022/ 07:30 The issuer is solely responsible for the...
Corporate News
03.03.2022 | DGAP-News
APONTIS PHARMA reports successful financial year 2021 - Single Pills as growth driver
DGAP-News: APONTIS PHARMA AG/ Key word(s): Preliminary Results/Annual Results 03.03.2022/ 07:30 The issuer is solely...
Corporate News
16.12.2021 | DGAP-News
APONTIS PHARMA strengthens management for future growth: Thomas Zimmermann appointed new CFO
DGAP-News: APONTIS PHARMA AG/ Key word(s): Personnel 16.12.2021/ 07:30 The issuer is solely responsible for the...
Corporate News
14.12.2021 | DGAP-News
APONTIS PHARMA and Midas Pharma announce development partnership to launch Single Pill with...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Product Launch/Alliance 14.12.2021/ 07:30 The issuer is solely...
Corporate News
18.11.2021 | DGAP-News
APONTIS PHARMA grows significantly faster than the overall market in the nine-month period 2021 -...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Quarterly/ Interim Statement/9 Month figures 18.11.2021/ 07:30 The issuer...
Corporate News
26.10.2021 | DGAP-News
APONTIS PHARMA announces market launch of new Single Pill
DGAP-News: APONTIS PHARMA AG/ Key word(s): Product Launch 26.10.2021/ 07:30 The issuer is solely responsible for the...
Corporate News
14.09.2021 | DGAP-News
APONTIS PHARMA announces launch of new Single Pill for more efficient treatment of hypertension and...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Product Launch 14.09.2021/ 07:30 The issuer is solely responsible for the...
Corporate News
11.08.2021 | DGAP-News
APONTIS PHARMA builds on strong position and profitability in first half of 2021 - preliminary...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Half Year Results/Half Year Report 11.08.2021/ 07:30 The issuer is solely...
Corporate News
28.07.2021 | DGAP-News
APONTIS PHARMA reports accelerated growth in first half of 2021 - Single Pill revenues +83% to EUR...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Preliminary Results/Half Year Results 28.07.2021/ 07:30 The issuer is...
Corporate News
12.07.2021 | DGAP-News
APONTIS PHARMA marks further success in the roll-out of Single Pill therapy
DGAP-News: APONTIS PHARMA AG/ Key word(s): Alliance 12.07.2021/ 07:30 The issuer is solely responsible for the...
Corporate News
18.06.2021 | DGAP-News
APONTIS PHARMA AG: Initial studies confirm that the share has a price potential of between 77% and...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Research Update 18.06.2021/ 07:30 The issuer is solely responsible for...
Corporate News
10.06.2021 | DGAP-News
APONTIS PHARMA AG: Post-Stabilisation disclosure - Partial exercise of the Greenshoe Option
DGAP-News: APONTIS PHARMA AG/ Key word(s): Miscellaneous 10.06.2021/ 21:23 The issuer is solely responsible for the...
Corporate News
10.06.2021 | DGAP-News
APONTIS PHARMA AG: Notification on the implementation of stabilization measures
DGAP-News: APONTIS PHARMA AG/ Key word(s): Miscellaneous 10.06.2021/ 21:20 The issuer is solely responsible for the...
Corporate News
28.05.2021 | DGAP-News
APONTIS PHARMA AG: Notification on the implementation of stabilization measures
DGAP-News: APONTIS PHARMA AG/ Key word(s): Miscellaneous 28.05.2021/ 20:05 The issuer is solely responsible for the...
Corporate News
20.05.2021 | DGAP-News
APONTIS PHARMA AG Trading Update: Strong revenues and earnings growth with Single Pills continues...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Quarterly/ Interim Statement 20.05.2021/ 07:30 The issuer is solely...
Corporate News
19.05.2021 | DGAP-News
APONTIS PHARMA AG: Notification on the implementation of stabilization measures
DGAP-News: APONTIS PHARMA AG/ Key word(s): Miscellaneous 19.05.2021/ 20:23 The issuer is solely responsible for the...
Corporate News
14.05.2021 | EQS-News
Apontis Pharma (APPH): Initiation - A phoenix rises
Edison Investment Research Limited 14-May-2021/ 07:00 GMT/BST London, UK, 14 May 2021 Apontis...
Corporate News
06.05.2021 | DGAP-News
APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share
DGAP-News: APONTIS PHARMA AG/ Key word(s): IPO 06.05.2021/ 20:09 The issuer is solely responsible for the content of...
Ad-hoc News
06.05.2021 | DGAP-Ad-hoc
APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share
APONTIS PHARMA AG/ Key word(s): IPO APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share...
Corporate News
29.04.2021 | DGAP-News
APONTIS PHARMA AG sets price range for planned IPO between EUR 18.50 and EUR 24.50 per share
DGAP-News: APONTIS PHARMA AG/ Key word(s): IPO 29.04.2021/ 08:30 The issuer is solely responsible for the content of...
Corporate News
21.04.2021 | DGAP-News
APONTIS PHARMA plans initial public offering
DGAP-News: APONTIS PHARMA AG/ Key word(s): IPO 21.04.2021/ 08:30 The issuer is solely responsible for the content of...
Sven Pauly
Thank you very much,
we have received your message
and will contact you shortly!
we have received your message
and will contact you shortly!